📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. (2017)

First Author: Tarafdar A

Attributed to: MICA: Determining the therapeutic potential of targeting mTORC-1/2 in chronic lymphocytic leukaemia - a pre-clinical study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2016-09-742049

PubMed Identifier: 27793879

Publication URI: http://europepmc.org/abstract/MED/27793879

Type: Journal Article/Review

Volume: 129

Parent Publication: Blood

Issue: 2

ISSN: 0006-4971